Literature DB >> 19120183

Anaplasma marginale Yucatan (Mexico) Strain. Assessment of low virulence and potential use as a live vaccine.

Sergio D Rodríguez Camarillo1, Miguel Angel García Ortiz, Edmundo E Rojas Ramírez, Germinal J Cantó Alarcón, Jesús F Preciado de la Torre, Rodrigo Rosario Cruz, Juan A Ramos Aragón, Ramón Aboytes Torres.   

Abstract

Anaplasma marginale Yucatan strain was found to have low virulence in cattle. We studied the virulence of this isolate by experimental inoculation of 113 susceptible cattle at increasing doses, after which only one animal required treatment for clinical disease. Subsequently, 104 cattle received a live vaccine of this strain by inoculation, which induced immunoprotection after heterologous challenged exposure with a different A. marginale isolate. In this study 14% of the immunized cattle required treatment as compared with the control nonimmunized cattle, in which 56% required treatment. The A. marginale vaccine strains used for the immunization studies had MSP1a variable regions that were different from those used for the challenge exposure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120183     DOI: 10.1196/annals.1428.067

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.

Authors:  Michael J Dark; Basima Al-Khedery; Anthony F Barbet
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

2.  Draft Genome Sequences of Anaplasma marginale Strains MEX-15-099-01 and MEX-31-096-01, Two Mexican Isolates with Different Degrees of Virulence.

Authors:  Fernando Martínez-Ocampo; Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Mayra Cobaxin Cárdenas; Edgar Dantán-González; Sergio Rodríguez-Camarillo
Journal:  Microbiol Resour Announc       Date:  2019-11-07

Review 3.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.